Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2020 | 3 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
anya pavlovsky
(3 results)?
Divergence of mutational signatures in association with breast cancer subtype.
Mol Carcinog. 2022 Nov;61(11):1056-1070. doi: 10.1002/mc.23461. Epub 2022 Sep 16.
Mol Carcinog. 2022.
PMID: 36111610
Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors.
Baram T, Erlichman N, Dadiani M, Balint-Lahat N, Pavlovski A, Meshel T, Morzaev-Sulzbach D, Gal-Yam EN, Barshack I, Ben-Baruch A.
Baram T, et al. Among authors: pavlovski a.
Cells. 2021 Jun 8;10(6):1429. doi: 10.3390/cells10061429.
Cells. 2021.
PMID: 34201054
Free PMC article.
Item in Clipboard
TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients.
Dadiani M, Necula D, Kahana-Edwin S, Oren N, Baram T, Marin I, Morzaev-Sulzbach D, Pavlovski A, Balint-Lahat N, Anafi L, Wiemann S, Korner C, Gal-Yam EN, Avivi C, Kaufman B, Barshack I, Ben-Baruch A.
Dadiani M, et al. Among authors: pavlovski a.
Cancer Immunol Immunother. 2020 Jul;69(7):1315-1326. doi: 10.1007/s00262-020-02549-0. Epub 2020 Mar 20.
Cancer Immunol Immunother. 2020.
PMID: 32198536
Free PMC article.
Item in Clipboard
ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.
Zundelevich A, Dadiani M, Kahana-Edwin S, Itay A, Sella T, Gadot M, Cesarkas K, Farage-Barhom S, Saar EG, Eyal E, Kol N, Pavlovski A, Balint-Lahat N, Dick-Necula D, Barshack I, Kaufman B, Gal-Yam EN.
Zundelevich A, et al. Among authors: pavlovski a.
Breast Cancer Res. 2020 Feb 3;22(1):16. doi: 10.1186/s13058-020-1246-5.
Breast Cancer Res. 2020.
PMID: 32014063
Free PMC article.
Item in Clipboard
Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.
Zundelevich A, Dadiani M, Kahana-Edwin S, Itay A, Sella T, Gadot M, Cesarkas K, Farage-Barhom S, Saar EG, Eyal E, Kol N, Pavlovski A, Balint-Lahat N, Dick-Necula D, Barshack I, Kaufman B, Gal-Yam EN.
Zundelevich A, et al. Among authors: pavlovski a.
Breast Cancer Res. 2020 Mar 12;22(1):28. doi: 10.1186/s13058-020-01265-y.
Breast Cancer Res. 2020.
PMID: 32164744
Free PMC article.
Item in Clipboard
Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer.
Dadiani M, Bossel Ben-Moshe N, Paluch-Shimon S, Perry G, Balint N, Marin I, Pavlovski A, Morzaev D, Kahana-Edwin S, Yosepovich A, Gal-Yam EN, Berger R, Barshack I, Domany E, Kaufman B.
Dadiani M, et al. Among authors: pavlovski a.
Clin Cancer Res. 2016 Jul 15;22(14):3651-62. doi: 10.1158/1078-0432.CCR-15-2313. Epub 2016 Mar 8.
Clin Cancer Res. 2016.
PMID: 26957561
Item in Clipboard
Cite
Cite